ALK and central nervous system neoplasm: From a subset of 2453 neoantigens identified in the solid and CNS tumor sub-cohort, we commonly predicted four neoepitopes (Table S3.4) from eight cell line models, of which two neoepitopes are associated with recurrent mutations H3-3A K27M and ALK F1174L.